In the present study, we investigated the hypothesis that inhibition of activated AKT promotes gemcitabine-induced apoptosis and confers gemcitabine sensitivity in cultured pancreatic cancer cells, in part, by PUMA upregulation. Here, BBC3 is linked to pancreatic neoplasm.